JAKARTA - Spokesperson for the Ministry of Health, Mohammad Syahril, said that the number of cases of acute progressive kidney failure or attypical progressive acute childney injury (AKI) treated at Cipto Mangunkusumo Hospital has been successfully suppressed. This is in line with a circular issued by the Ministry of Health regarding the prohibition of prescribing or using sirop drugs at all health facilities in Indonesia to prevent additional acute kidney failure cases as of 18 October. "The circular letter from the Ministry of Health has succeeded in preventing the addition of new cases. At the RSCM as a national referral hospital for the kidneys, there have been no new patients since October 22," Syahril said in a virtual press conference, Tuesday, October 25. In the development of acute kidney failure cases as of October 24, there were 255 cases originating from 26 provinces. A total of 143 cases died with a death rate of 56 percent. In this data, there are an additional 10 cases and 2 deaths from previous records. However, Syahril emphasized that this addition was a case that was long late reported which occurred in September and early October 2022. "So it's not a new case, huh," he said. Furthermore, Syahril revealed that the government has brought in 26 vials of anti-dotum drugs or bidders, namely 26 vials from Singapore and 16 vials from Australia. Furthermore, the government will bring in 200 vials of fomezole from Japan and from the United States. "This medicine will soon be distributed to government referral hospitals throughout Indonesia and this drug is free, free of charge for patients," said Syahril. Dari hasil pemberian obat fomepizole di RSCM, lanjut Syahril, 10 dari 11 pasien terus mengalami perbaikan secara klinis, serta tidak ada kematian dan tidak ada penburukan lebih lanjut. "The child has begun to be able to remove his small water or urine. From the results of laboratory examinations, the ethylene glycol levels of the 10 children have not detected any harmful substances," he added.

The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)